About Galderma
Galderma is a publicly listed company based in Zug (Switzerland) founded in 1981, and was acquired by EQT in May 2019. Dermatological products are manufactured to treat various skin conditions. It operates on a HealthTech and Direct-to-Consumer (D2C) model. Galderma has completed 3 acquisitions, including Alastin Skincare, Q-Med and ZO Skin Health. Its website galderma.com draws about 165 thousand monthly visits. Its Indian entity Galderma India Private Limited reported revenue of ₹1,823 Cr. Galderma offers products and services including Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. Its focus areas include Healthcare, Pharmaceuticals and Dermatology. Its competitors include Lalique Group, Zino Davidoff and Mibelle Group.
Company details
Galderma is dedicated to advancing dermatology through innovative solutions tailored to individual skin needs. The company operates across Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology sectors. Premium brands and cutting-edge products are developed to address a wide spectrum of skin conditions. With a global presence, operations are supported in numerous countries, ensuring accessibility to diverse markets. Sustainability and governance are integrated into the business strategy, emphasizing responsible practices. Collaboration with healthcare professionals and patients is prioritized to enhance skin health outcomes worldwide.
- Headquarters Zug, Switzerland
- Stage Public
- SectorsConsumer
- Website category Health
- Phone•••• ••••
- Website galderma.com
- Social LinkedIn X Instagram
- Acquired by EQT (May 2019)
- Legal Name Galderma Group Ag
- Indian entity revenue₹1,823 Cr
FY 2026 · +44% YoY
- Indian entity net profit₹287 Cr
FY 2026 · 16% margin
- Indian entity EBITDA₹396 Cr
FY 2026 · 22% margin
- InvestorsNestlé
& 3 more
- Investments & AcquisitionsAlastin Skincare
& 2 more
- Acquired by
Associated legal entities of Galderma
Galderma operates through Galderma India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Galderma India Private Limited CIN U24110MH1999PTC118113 | Active | 02 Feb 1999 | Goregaon East, Maharashtra | ₹1,823 Cr | 451 | 4 | View details |
Products & Services of Galderma
Galderma offers a comprehensive portfolio of products and services, including Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology.
Solutions for aesthetic skin enhancement are provided by Galderma.
Skincare products for various skin conditions are offered.
Therapeutic solutions for skin diseases are developed by Galderma.
Funding Insights of Galderma
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Galderma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2024 | Seed | – | – |
4 investors in total: 4 institutional.
Investors in Galderma
Galderma has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Nestlé, EQT and PSP Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
EQT is recognized as a global investment organization focused on value creation. | 1994 | eqtgroup.com | Stockholm, Sweden | |
Multi-category food and beverage products are produced and distributed globally. | 1866 | nestle.com | Vevey, Switzerland | |
Manages investments for public sector pensions in capital markets, real estate, and private equity. | 1999 | investpsp.com | Montreal, Canada | |
| ritcap.com |
Investor details for Galderma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Galderma India Private Limited (Galderma)
Galderma India Private Limited is the primary company behind Galderma. The board of Galderma India Private Limited currently have 4 directors; the longest-serving is Nimit Mahendra Sanghvi, appointed in 2021. 15 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nimit Mahendra Sanghvi DIN 08424666 | Director | 08 Apr 2021 | 5 yrs 6 mo | Galderma India Private Limited |
| Hon Keong Choo DIN 09099354 | Director | 17 Sep 2021 | 5 yrs 1 mo | Galderma India Private Limited |
| Sandeep Mahadev Desai DIN 09099414 | Director | 17 Sep 2021 | 5 yrs 1 mo | Galderma India Private Limited |
| Raghavendra Sadashiva DIN 09843954 | Managing Director | 01 Jan 2023 | 3 yrs 10 mo | Galderma India Private Limited |
People of Galderma
671 people are tracked at Galderma (220 in leadership, 451 in team).
| Name | Role | Group |
|---|---|---|
Charlie G. | Sr. Director, Franchise & Omnichannel Marketing | Leadership |
Elsa Locardi | Head Of R&d Project Management | Leadership |
Eddy Guinet | Global Head Of Talent Acquisition | Leadership |
Kristin Anderson | US Sr Talent Acquisition Partner | Leadership |
Gracy D. | Global Digital IT Director | Leadership |
Jim Malley | Head Of HR For Prescription Business Unit | Leadership |
Satomi Akaza | Cmo/packaging Procurement Project Support | Leadership |
Chinatsu Kitahara | Representative Director & President, Japan | Leadership |
Aaron Rivera | Director, Revenue Strategy & Operations | Leadership |
Alexander Mueller | Head Of Human Resources EMEA & Canada | Leadership |
Dong Shao | Director, Market Access And Channel Strategy - Nemolizumab | Leadership |
Eugene Yong | Head Of Information Technology JPAC Regional | Leadership |
Eduardo Kondo | Global IT Head - International Markets And Global Infrastructure | Leadership |
Emmanuel Ewara | Director, Patient Access & Experience | Leadership |
Christian Marcoux | Chief Communications Officer | Leadership |
Massimo Bellato | Regional Head Of Ecommerce & Digital Marketing EMEA & Canada | Leadership |
Ligia Carla Santos | General Manager - Brazil | Leadership |
Tim Lanier | Vice President Of Sales | Leadership |
| Director Finance | Leadership | |
Bernadette Fabian | Chief Financial Officer | Leadership |
651 more people are available in the full profile.
Complete people profiles for Galderma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Galderma
Galderma is a publicly listed company on the SIX with ticker symbol GALD in Switzerland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date22 Mar 2024
- Listed onSWX: GALD
- Listed entityGalderma Group AG
- Exchange sectorHealth technology
- ISINCH1335392721
- Share price163.65 CHF (-0.15% on the day) · 2026-05-11
- Market capitalisation38,487,627,998.00 CHF
- Price to earnings77.2
- EPS (diluted, trailing year)2.12 CHF
- Dividend yield0.21%
- Volume (last session)97,576
- Analyst consensusBuy
Financials of Galderma
Figures of Galderma India Private Limited, the primary company behind Galderma, for FY 2026. Revenue was ₹1,823 Cr (+44% year on year). Net profit was ₹287 Cr (16% margin). EBITDA was ₹396 Cr (22% margin). Revenue has grown at a compounded annual rate of +49% over three years and +54% over five years.
- ₹1,823 CrRevenue · FY 2026 · +44% YoY
- ₹287 CrNet profit · 16% margin
- ₹396 CrEBITDA · 22% margin
- ₹2.42 CrPaid-up capital
- 451Employees (provident fund records)
- +49%Revenue CAGR, 3 years
- +54%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 4.32B CHF | 509.1M CHF | 970.0M CHF |
| 2024 | 3.88B CHF | 203.4M CHF | 828.7M CHF |
| 2023 | 3.67B CHF | -51.4M CHF | 766.1M CHF |
| 2022 | 3.59B CHF | -94.1M CHF | 592.2M CHF |
| 2021 | 3.12B CHF | -141.1M CHF | 529.0M CHF |
Balance sheet, profit and loss, cash flow and ratios of Galderma India Private Limited are on its company page.
Detailed financial statements for Galderma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Galderma
Galderma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Alastin Skincare, Q-Med and ZO Skin Health.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Skin care products are manufactured and distributed globally through partners. | zoskinhealth.com | Orange, United States | 2008 | Oct 2026 | $1.5B | |
Brand of skin care products | alastin.com | Carlsbad, United States | 2015 | Nov 2021 | •••• | |
Medical implants based on Non-Animal Stabilized Hyaluronic Acid for esthetics, orthopedics, urogynecology, and cell therapy. | q-med.com | Uppsala, Sweden | 1987 | Dec 2011 | $1.08B |
Complete acquisition details for Galderma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Galderma
8 dated milestones of Galderma across 45 years, from founding to its latest funding, stage changes and deals.
- Founded Galderma is founded.
- Acquisition Acquires Q-Med.
- Exit Acquired by Nestle.
- Exit Acquired by EQT.
- Acquisition Acquires Alastin Skincare.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires ZO Skin Health.
Competitors of Galderma
Galderma has 3 listed competitors in our database. They include Lalique Group, Zino Davidoff and Mibelle Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lalique-group.com | 2000 | Zurich, Switzerland | Creator, developer, marketer, and global distributor of luxury products, including perfumes, cosmetics, crystal, and jewelry | |||
| zinodavidoff.com | 1980 | Basel, Switzerland | Provides luxury accessories, fragrances, coffee, and lifestyle products globally. | |||
| mibellegroup.com | 2012 | Buchs, Switzerland | Multibrand group offering personal and healthcare products |
Detailed competitors of Galderma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Galderma
The website of Galderma (galderma.com) receives about 164.6K visits a month and ranks #278,436 among all websites worldwide, #9,539 in Health.
- Monthly visits164.6K
▲ 0.9% vs previous month
- Unique visitors81.6K
per month
- Global rank#278,436
among all websites
- Category rank#9,539
Health · Health
- Bounce rate46%
- Pages per visit1.8
- Average visit31 sec
- DevicesDesktop 29% · Mobile 71%
Websites whose visitors overlap most with Galderma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bms.com | 100% | 809.8K | #67,210 | View details | |
| abbott.com | 88% | 917.2K | #65,577 | View details | |
| e2.co.za | 88% | 680.7K | #1,918,699 | View details | |
| baxter.com | 88% | 401.8K | #127,908 | View details | |
galdermaaesthetics.com | galdermaaesthetics.com | 80% | #1,583,861 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Galderma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Galderma
Complete news archive for Galderma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Galderma
Galderma was founded in 1981 and raised its 1st funding round 43 years after it was founded.
Galderma is headquartered in Zug, Switzerland. It is registered at Zug, Zug, Switzerland.
The primary company behind Galderma, Galderma India Private Limited, reported revenue of ₹1,823 Cr for FY 2026, up 44% year on year.
Galderma is dedicated to advancing dermatology through innovative solutions tailored to individual skin needs. The company operates across Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology sectors. Premium brands and cutting-edge products are developed to address a wide spectrum of skin conditions. With a global presence, operations are supported in numerous countries, ensuring accessibility to diverse markets. Sustainability and governance are integrated into the business strategy, emphasizing responsible practices. Collaboration with healthcare professionals and patients is prioritized to enhance skin health outcomes worldwide.
Galderma's top competitors include Mibelle Group, Lalique Group and Zino Davidoff.
Galderma offers Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology.
Yes, Galderma is publicly traded on SIX under the ticker symbol GALD.
Galderma has made 3 acquisitions, including Alastin Skincare, Q-Med, and ZO Skin Health.
Galderma has 4 investors. Key investors include Nestlé, EQT, PSP Investments, and RIT Capital Partners.
Galderma operates through Galderma India Private Limited.
Yes. Galderma was acquired by EQT in May 2019.
The legal entities of Galderma currently have 4 directors, including Nimit Mahendra Sanghvi, Hon Keong Choo, Sandeep Mahadev Desai and others.